Old Web
English
Sign In
Acemap
>
authorDetail
>
Signe Diness Vindeloev
Signe Diness Vindeloev
Genmab
Oncology
Medicine
Internal medicine
Cohort
Antibody
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 3 trial (GCT3013-05) of epcoritamab versus standard of care in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
2021
Journal of Clinical Oncology
Catherine Thieblemont
Michael Roost Clausen
Anna Sureda Balari
Pier Luigi Zinzani
Christopher P. Fox
Su Young Kim
Signe Diness Vindeloev
Pieternella J. Lugtenburg
Show All
Source
Cite
Save
Citations (0)
A single arm, phase 2, multicenter, international trial of tisotumab vedotin (HuMax-TF-ADC) in previously treated, recurrent or metastatic cervical cancer.
2018
Journal of Clinical Oncology
Robert L. Coleman
N Concin
Thomas J. Herzog
Linn Woelber
Mansoor Raza Mirza
Bradley J. Monk
David Cibula
Domenica Lorusso
Antonio González-Martín
Kristian Windfeld
Jeroen Lammerts van Bueren
Signe Diness Vindeloev
Reshma Rangwala
Ignace Vergote
Show All
Source
Cite
Save
Citations (0)
1